Who owns MAIA BIOTECHNOLOGY INC?
- Ticker: MAIA
- CUSIP Number: 552641102
Tip: Access positions for across all investors
Analyze quarterly positions in Maia Biotechnology with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Maia Biotechnology stock
Who bought or sold MAIA BIOTECHNOLOGY INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Solas Capital Management | 3.0M | $4.4M | -29% | Jun 2026 |
|
| Alyeska Investment Group | 2.5M | $3.6M | 0% | Jun 2026 |
|
| Vanguard Capital Management | 2.4M | $3.5M | 16% | Jun 2026 |
|
| 683 Capital Management | 1.1M | $1.5M | 0% | Jun 2026 |
|
| Centric Wealth Management | 797k | $1.1M | 0% | Jun 2026 |
|
| Cable Car Capital | 515k | $741k | -21% | Jun 2026 |
|
| Geode Capital Management | 504k | $727k | 40% | Jun 2026 |
|
| Bleichroeder | 500k | $720k | 0% | Jun 2026 |
|
| Renaissance Technologies | 416k | $599k | 100% | Jun 2026 |
|
| Vanguard Fiduciary Trust | 337k | $485k | 69% | Jun 2026 |
|
| Bleakley Financial Group | 182k | $262k | 100% | Jun 2026 |
|
| State Street Corporation | 139k | $195k | 84% | Mar 2026 |
|
| BlackRock | 128k | $179k | 19% | Mar 2026 |
|
| Northern Trust | 125k | $180k | 138% | Jun 2026 |
|
| Bridgeway Capital Management | 76k | $109k | 111% | Jun 2026 |
|
| Two Sigma Investments | 50k | $73k | 100% | Jun 2026 |
|
| Envestnet Asset Management | 44k | $64k | 100% | Jun 2026 |
|
| Susquehanna International | 35k | $51k | 100% | Jun 2026 |
|
| Pvg Asset Management | 34k | $49k | 0% | Jun 2026 |
|
| UBS Group | 33k | $48k | -36% | Jun 2026 |
|
| Citadel Advisors | 25k | $36k | 100% | Jun 2026 |
|
| Cetera Investment Advisers | 23k | $33k | 100% | Jun 2026 |
|
| Atria Investments | 21k | $30k | 100% | Jun 2026 |
|
| Centerpoint Advisory Group | 16k | $23k | 0% | Jun 2026 |
|
| Wealth Enhancement Advisory Services | 15k | $21k | 100% | Jun 2026 |
|
| Morgan Stanley | 14k | $19k | 1286% | Mar 2026 |
|
| Vanguard Global Advisers | 11k | $16k | 0% | Jun 2026 |
|
| Catalyst Funds Management Pty | 11k | $15k | 100% | Mar 2026 |
|
| Advisor Group Holdings | 8.3k | $12k | 0% | Jun 2026 |
|
| Daytona Street Capital | 7.5k | $11k | 0% | Jun 2026 |
|
| Barclays | 4.2k | $6.0k | 100% | Jun 2026 |
|
| Tower Research Capital | 3.2k | $4.6k | 100% | Jun 2026 |
|
| Mercer Global Advisors | 455.00 | $655.018000 | 100% | Jun 2026 |
|
| Jones Financial Companies, L.L | 228.00 | $321.001200 | 0% | Jun 2026 |
|
| Caitong International Asset Management | 210.00 | $302.001000 | 100% | Jun 2026 |
|
| Wells Fargo & Company | 200.00 | $288.000000 | 100% | Jun 2026 |
|
| Citigroup | 22.00 | $31.000200 | 100% | Mar 2026 |
|
Who sold out of Maia Biotechnology?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Corsair Capital Management | Mar 2026 | 100k | $140k |
| Creative Planning | Mar 2026 | 29k | $40k |
| Comprehensive Portfolio Management | Mar 2026 | 23k | $32k |
| O'shaughnessy Asset Management | Mar 2026 | 20k | $28k |
| Cambridge Investment Research Advisors | Mar 2026 | 11k | $15k |
| Curio Wealth | Mar 2026 | 2.0k | $2.8k |
| MAI Wealth Advisors | Mar 2026 | 675.00 | $945.000000 |
| Royal Bank of Canada | Mar 2026 | 268.00 | $0 |